Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Blüm Holdings, Inc. | Theralese® Technologies Inc.
MP3•Episode home
Manage episode 417247283 series 180440
Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Blüm Holdings, Inc. (OTCQB: BLMH), a cannabis company with operations throughout California, is pleased to announce the execution of a Binding Letter of Intent with Operators Only Corporation to add three additional dispensaries to its retail portfolio. If completed, the Proposed Acquisition could represent a significant milestone in Blüm Holdings’ expansion strategy and may help solidify the Company’s position as a key player in Northern California’s retail landscape.
Operators Only owns and operates three retail stores in Sacramento, including a flagship Cookies cannabis dispensary located in downtown Sacramento, a dispensary in North Sacramento, and another in South Sacramento.
Theralase® Technologies Inc. (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (“PDCs“) for the safe and effective destruction of various cancers, bacteria and viruses is pleased to announce that Dr. Michael Jewett has joined Theralase®, in the role of an independent consultant, to assist the Company in the completion of enrollment of patients in the Phase II Bacillus Calmette-Guérin (“BCG“)-Unresponsive Non Muscle Invasive Bladder Cancer (“NMIBC“) Carcinoma In-Situ (“CIS“) clinical study.
For more information, please visit StockDayMedia.com
Operators Only owns and operates three retail stores in Sacramento, including a flagship Cookies cannabis dispensary located in downtown Sacramento, a dispensary in North Sacramento, and another in South Sacramento.
Theralase® Technologies Inc. (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (“PDCs“) for the safe and effective destruction of various cancers, bacteria and viruses is pleased to announce that Dr. Michael Jewett has joined Theralase®, in the role of an independent consultant, to assist the Company in the completion of enrollment of patients in the Phase II Bacillus Calmette-Guérin (“BCG“)-Unresponsive Non Muscle Invasive Bladder Cancer (“NMIBC“) Carcinoma In-Situ (“CIS“) clinical study.
For more information, please visit StockDayMedia.com
1487 episodes
MP3•Episode home
Manage episode 417247283 series 180440
Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Blüm Holdings, Inc. (OTCQB: BLMH), a cannabis company with operations throughout California, is pleased to announce the execution of a Binding Letter of Intent with Operators Only Corporation to add three additional dispensaries to its retail portfolio. If completed, the Proposed Acquisition could represent a significant milestone in Blüm Holdings’ expansion strategy and may help solidify the Company’s position as a key player in Northern California’s retail landscape.
Operators Only owns and operates three retail stores in Sacramento, including a flagship Cookies cannabis dispensary located in downtown Sacramento, a dispensary in North Sacramento, and another in South Sacramento.
Theralase® Technologies Inc. (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (“PDCs“) for the safe and effective destruction of various cancers, bacteria and viruses is pleased to announce that Dr. Michael Jewett has joined Theralase®, in the role of an independent consultant, to assist the Company in the completion of enrollment of patients in the Phase II Bacillus Calmette-Guérin (“BCG“)-Unresponsive Non Muscle Invasive Bladder Cancer (“NMIBC“) Carcinoma In-Situ (“CIS“) clinical study.
For more information, please visit StockDayMedia.com
Operators Only owns and operates three retail stores in Sacramento, including a flagship Cookies cannabis dispensary located in downtown Sacramento, a dispensary in North Sacramento, and another in South Sacramento.
Theralase® Technologies Inc. (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (“PDCs“) for the safe and effective destruction of various cancers, bacteria and viruses is pleased to announce that Dr. Michael Jewett has joined Theralase®, in the role of an independent consultant, to assist the Company in the completion of enrollment of patients in the Phase II Bacillus Calmette-Guérin (“BCG“)-Unresponsive Non Muscle Invasive Bladder Cancer (“NMIBC“) Carcinoma In-Situ (“CIS“) clinical study.
For more information, please visit StockDayMedia.com
1487 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.